UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Journal of clinical oncology, 2006-01, Vol.24 (3), p.467-475

2006

Volltextzugriff (PDF)

Co-administration of cyclosporin enables oral therapy with paclitaxel

The Lancet (British edition), 1998-07, Vol.352 (9124), p.285-285

1998

Volltextzugriff (PDF)

Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxel

Anti-cancer drugs, 2001-08, Vol.12 (7), p.591-593

2001

Volltextzugriff (PDF)

SURVEILLANCE CAN BE THE STANDARD OF CARE FOR STAGE I NONSEMINOMATOUS TESTICULAR TUMORS AND EVEN HIGH RISK PATIENTS

The Journal of urology, 2001-12, Vol.166 (6), p.2166-2170

2001

Volltextzugriff (PDF)

Clinical pharmacokinetics of topotecan

Clinical pharmacokinetics, 1996-08, Vol.31 (2), p.85-102

1996

Volltextzugriff (PDF)

Clinical pharmacology of anticancer agents in relation to formulations and administration routes

Cancer treatment reviews, 1999-04, Vol.25 (2), p.83-102

1999

Volltextzugriff (PDF)

Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimens

Clinical drug investigation, 1998, Vol.15 (4), p.327-335

1998

Volltextzugriff (PDF)

Hypersensitivity Reactions to the Taxanes Paclitaxel and Docetaxel

Clinical drug investigation, 1997-11, Vol.14 (5), p.418-427

1997

Volltextzugriff (PDF)

Urinary excretion of paclitaxel and metabolites in a large series study

Journal of oncology pharmacy practice, 1998-09, Vol.4 (3), p.159-164

1998

Volltextzugriff (PDF)

Extravasation of topotecan, a report of two cases

Journal of oncology pharmacy practice, 1997-06, Vol.3 (2), p.115-116

1997

Volltextzugriff (PDF)

SURVEILLANCE CAN BE THE STANDARD OF CARE FOR STAGE I NONSEMINOMATOUS TESTICULAR TUMORS AND EVEN HIGH RISK PATIENTS

The Journal of urology, 2001-12, p.2166-2170

2001

Volltextzugriff (PDF)

Hypersensitivity reactions to etoposide

The Annals of pharmacotherapy, 1996-04, Vol.30 (4), p.367-371

1996

Volltextzugriff (PDF)

Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin

Cancer chemotherapy and pharmacology, 1995-05, Vol.37 (3), p.266-270

1995

Volltextzugriff (PDF)

Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients. Commentary

The Journal of urology, 2001, Vol.166 (6), p.2166-2170

2001

Volltextzugriff (PDF)

Pharmacokinetics of paclitaxel administered in combination with cisplatin, etoposide and bleomycin in patients with advanced solid tumours

Cancer chemotherapy and pharmacology, 1999, Vol.44 (4), p.349-353

1999

Volltextzugriff (PDF)

Phase I Clinical and Pharmacokinetic Study of Topotecan Administered by a 24-Hour Continuous Infusion

Journal of clinical oncology, 1996-02, Vol.14 (2), p.689

1996

Volltextzugriff (PDF)

Multicenter phase II study of spiroplatin

Oncology, 1992, Vol.49 (2), p.99-103

1992

Volltextzugriff (PDF)

The pharmacokinetics of reduced folates after intraperltoneal and intravenous administration of racemic [6S,R]-folinic acid

Cancer chemotherapy and pharmacology, 1994-03, Vol.35 (2), p.144-148

1994

Volltextzugriff (PDF)

Five‐year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin

Cancer, 1984-10, Vol.54 (8), p.1521-1524

1984

Volltextzugriff (PDF)

Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur

PDA journal of pharmaceutical science and technology, 1997-03, Vol.51 (2), p.89

1997

Volltextzugriff (PDF)

Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors

Pharmacy world and science, 1998-08, Vol.20 (4), p.161-172

1998

Volltextzugriff (PDF)

Acute leukemia following therapy for teratoma

European journal of cancer & clinical oncology, 1984-01, Vol.20 (4), p.501-502

1984

Volltextzugriff (PDF)

Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery

European journal of cancer & clinical oncology, 1991, Vol.27 (6), p.695-698

1991

Volltextzugriff (PDF)

Phase II study of 5-Aza-2′-deoxycytidine in advanced ovarian carcinoma

European journal of cancer & clinical oncology, 1990-02, Vol.26 (2), p.137-138

1990

Volltextzugriff (PDF)

Phase I clinical study of LL-D49194α1 with retrospective pharmacokinetic investigations in mice and humans

Cancer chemotherapy and pharmacology, 1993-09, Vol.31 (5), p.395-400

1993

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Biological And Medical Sciences
(13)
Humans
(13)
Medical Sciences
(13)
Pharmacology. Drug Treatments
(11)
Oncology
(10)
Antineoplastic Agents
(9)
Chemotherapy
(8)
Pharmacology & Pharmacy
(7)
Adult
(6)
Male
(5)
Neoplasms - Drug Therapy
(5)
Pharmacokinetics
(5)
Middle Aged
(4)
Administration, Oral
(3)
Enzyme Inhibitors - Pharmacokinetics
(3)
Paclitaxel - Administration & Dosage
(3)
Topotecan
(3)
Adolescent
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Co-administration of cyclosporin enables oral therapy with paclitaxel

Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxel

SURVEILLANCE CAN BE THE STANDARD OF CARE FOR STAGE I NONSEMINOMATOUS TESTICULAR TUMORS AND EVEN HIGH RISK PATIENTS

Clinical pharmacokinetics of topotecan

Clinical pharmacology of anticancer agents in relation to formulations and administration routes

Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimens

Hypersensitivity Reactions to the Taxanes Paclitaxel and Docetaxel

Urinary excretion of paclitaxel and metabolites in a large series study

Extravasation of topotecan, a report of two cases

SURVEILLANCE CAN BE THE STANDARD OF CARE FOR STAGE I NONSEMINOMATOUS TESTICULAR TUMORS AND EVEN HIGH RISK PATIENTS

Hypersensitivity reactions to etoposide

Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin

Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients. Commentary

Pharmacokinetics of paclitaxel administered in combination with cisplatin, etoposide and bleomycin in patients with advanced solid tumours

Phase I Clinical and Pharmacokinetic Study of Topotecan Administered by a 24-Hour Continuous Infusion

Multicenter phase II study of spiroplatin

The pharmacokinetics of reduced folates after intraperltoneal and intravenous administration of racemic [6S,R]-folinic acid

Five‐year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin

Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur

Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors

Acute leukemia following therapy for teratoma

Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery

Phase II study of 5-Aza-2′-deoxycytidine in advanced ovarian carcinoma

Phase I clinical study of LL-D49194α1 with retrospective pharmacokinetic investigations in mice and humans

Aktive Filter

Suchergebnisse filtern